Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma

APMIS

Volumn 115, Issue 8, 2007, Pages 906-910

  Wang, Sheng Lan ^a,b   Li, Shau Hsuan ^c   Chen, Wan Tzu ^a   Chai, Chee Yin ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

D2 40; Papillary carcinoma; Thyroid

Indexed keywords

BIOLOGICAL MARKER; D2 40; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE MARKER; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOREACTIVITY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID GLAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34547924446     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2007.apm_653.x     Document Type: Article

References (14)

1. Carcangiu ML, Zampi G, Rosai J. Papillary thyroid carcinoma: a study of its many moprhologic expressions and clinical correlates. Pathol Annu 1985 20 (Pt. 1 1 44.
2. Charbord P, L'Heritier C, Cukersztein W, Lumbroso J, Tubiana M. Radioiodine treatment in differentiated thyroid carcinomas. Treatment of first local recurrences and bone and lung metastases. Ann Radiol 1977 20:783 6.
3. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 2004 28:1336 40.
4. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005 166:913 21.
5. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcoma. Mol Pathol 2002 15:434 40.
6. Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 2005 18:105 10.
7. Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumors. Br J Cancer 1999 80:569 78.
8. Naganuma H, Murayama H, Ohtani N, Takaya K, Mori Y, Sakai N, et al. Optically clear nuclei in papillary carcinoma of thyroid: demonstration of one of the fixation artifacts and its practical usefulness. Pathol Int 2000 50:113 8.
9. Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 2002 26:1508 14.
10. Yonemura Y, Endou Y, Tabachi K, Kawamura T, Yun HY, Kameya T, et al. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol 2006 37:1193 9.
11. Zeng Y, Opeskin K, Horvath LG, Sutherland RL, Williams ED. Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 2005 65:222 30.
12. Renyi-Vamos F, Tovari J, Fillinger J, Pandor P, Kenessey I, Ostoros G, et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005 11:7344 53.
13. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Solverman JF. Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 2006 19:1317 23.
14. Giorgadze TA, Baloch ZW, Pasha T, Zhang PJ, LiVolsi VA. Lymphatic and blood vessel density in the follicular patterned lesions of thyroid. Mod Pathol 2005 18:1424 31.